Emergent BioSolutions Inc. provided revenue guidance for the second quarter of 2024. For the quarter, the company reported total revenue of $160 million to $210 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.72 USD | -0.84% | -8.88% | +96.67% |
May. 02 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
May. 02 | Sector Update: Health Care | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+96.67% | 247M | |
+38.59% | 727B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+13.00% | 238B | |
+6.94% | 204B | |
-6.42% | 203B | |
+4.23% | 161B | |
-1.70% | 160B |
- Stock Market
- Equities
- EBS Stock
- News Emergent BioSolutions Inc.
- Emergent BioSolutions Inc. Provides Revenue Guidance for the Second Quarter of 2024